Human Hip Replacement
A total hip replacement replaces your arthritic hip joint and eliminates the damaged bearing surfaces
that are causing you pain. The design of the implant offers you renewed stability and minimizes the
wear process.
http://www.bonesmart.org/hip_replacement.php?gclid=CMuKm6uP4JgCFSUgDQodmTzaeA
MAKO does hip replacements via a robotic system.
MAKO Surgical Corp. Introduces MAKOplasty(R) Total Hip Arthroplasty
8:00 AM ET 9/19/11 | GlobeNewswire
Robotic Arm-Assisted Technology Provides Surgeons With
Consistently Reproducible Precision in Hip Replacement Surgery
MAKOplasty Total Hip Arthroplasty is Designed to Help Surgeons Restore
Patient Mobility and Lifestyle
FT. LAUDERDALE, Fla., Sept. 19, 2011 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:
MAKO) today announced the commercial availability of the RIO(R) Robotic Arm Interactive
Orthopedic System for use in total hip replacement procedures, called MAKOplasty(R) Total Hip
Arthroplasty.
MAKO's total hip replacement application is designed to support the surgeon's ability to more
accurately align and position the implants relative to the needs of a patient. This may reduce potential
complications associated with conventional hip replacement surgery. MAKOplasty Total Hip
Arthroplasty provides a surgeon with a pre-operative 3-D reconstruction of the patient's hip and is
used to develop the patient-specific surgical plan. The robotic-arm then assists the surgeon during the
procedure to accurately prepare the joint and optimally place hip implants.
"MAKOplasty Total Hip Arthroplasty provides a significant advantage to me as a surgeon and to my
patients. It provides quantitative knowledge for what were difficult judgment decisions inherent in
manually performed operations," said Lawrence Dorr, M.D., founder and medical director of The Dorr
Arthritis Institute in Los Angeles. "When I finish a hip replacement I no longer am anxious to see the x-
ray because I know I've got the implants, leg length and offset correct. It makes recovery easier for
patients, including their comfort, activities and protection from dislocation. This robotic guided
operation is better for both me and my patients."
A recently published Massachusetts General Hospital study reported that, over a sustained period of
study of 1,823 hips, only 50 percent of acetabular cups (cup-shaped sockets of the hip joint) were
positioned in the acceptable range. Mal-positioning of acetabular cups in conventional hip replacement
surgery may lead to impingement that can cause dislocation, fracture, and increased implant wear.1
Nearly 300,000 primary hip replacement surgeries are performed annually in the United States using
conventional techniques.
"We're pleased to introduce MAKOplasty Total Hip Arthroplasty as an option for surgeons who
perform total hip replacement," said Maurice R. FerrÄ—, M.D., president and chief executive officer of
MAKO Surgical Corp. "We believe that surgeons and patients will benefit from a technology that can
help improve accuracy and precision in surgery and result in a potential reduction of the complications
reported from conventional approaches."
According to a June 2011 survey conducted by Harris Interactive, six in 10 adults ages 40+ are afraid
they will lose their ability to walk and/or move around without pain. Nearly nine out of 10 survey
respondents thought that hip replacement gives people back their independence and believe it can
restore a better quality of life.2
"With my hip pain, I really couldn't walk or sleep, and going up and down stairs was very painful,"
said Victoria Handy Smudzinski, 44, who has osteoarthritis of the hip and had a total hip replacement
with MAKOplasty. "I'm glad that I had the MAKOplasty procedure because already I am on my way
back to a normal life."
Approximately 10 million Americans suffer from osteoarthritis (OA) of the hip, or the wearing away of
the cartilage that cushions the bones of the hips, causing hip pain and stiffness, which can affect
mobility, including walking and bending. Hip OA is the most common cause of hip replacement
surgery.3
MAKOplasty Total Hip Arthroplasty is the newest application for MAKO's RIO robotic arm system
and builds upon five years of MAKO's existing MAKOplasty Partial Knee Resurfacing procedure for
patients with early to mid-stage osteoarthritis of the knee. MAKOplasty Total Hip Arthroplasty was
cleared for use in the U.S. by the FDA in February 2010.
About MAKO Surgical Corp.
MAKO Surgical Corp. is a medical device company that markets both its RIO(R) Robotic-Arm
Interactive Orthopedic system and its proprietary RESTORIS(R) implants for orthopedic knee and hip
procedures called MAKOplasty(R). The RIO is a surgeon-interactive tactile surgical platform that
incorporates a robotic arm and patient-specific visualization technology, which enables precise,
consistently reproducible bone resection for the accurate insertion and alignment of MAKO's
RESTORIS implants. The MAKOplasty solution is comprised of technologies enabled by an intellectual
property portfolio including more than 300 U.S. and foreign, owned and licensed, patents and patent
applications. Additional information can be found at www.makosurgical.com.
Forward-Looking Statements
This press release contains forward-looking statements regarding, among other things, statements
related to expectations, goals, plans, objectives and future events. MAKO intends such forward-
looking statements to be covered by the safe harbor provisions for forward-looking statements
contained in Section 21E of the Securities Exchange Act of 1934 and the Private Securities Reform Act
of 1995. In some cases, forward-looking statements can be identified by the following words: "may,"
"will," "could," "would," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict,"
"project," "potential," "continue," "ongoing" or the negative of these terms or other comparable
terminology, although not all forward-looking statements contain these words. These statements are
based on the current estimates and assumptions of our management as of the date of this press release
and are subject to risks, uncertainties, changes in circumstances, assumptions and other factors that
may cause actual results to differ materially from those indicated by forward-looking statements,
many of which are beyond MAKO's ability to control or predict. Such factors, among others, may have
a material adverse effect on MAKO's business, financial condition and results of operations and may
include the potentially significant impact of a continued economic downturn or delayed economic
recovery on the ability of MAKO's customers to secure adequate funding, including access to credit,
for the purchase of MAKO's products or cause MAKO's customers to delay a purchasing decision,
changes in competitive conditions and prices in MAKO's markets, unanticipated issues relating to
intended product launches, decreases in sales of MAKO's principal product lines, increases in
expenditures related to increased or changing governmental regulation or taxation of MAKO's
business, unanticipated issues in complying with regulatory requirements related to MAKO's current
products or securing regulatory clearance or approvals for new products or upgrades or changes to
MAKO's current products, the impact of the recently enacted United States healthcare reform
legislation on hospital spending, reimbursement, and the taxing of medical device companies, loss of
key management and other personnel or inability to attract such management and other personnel and
unanticipated intellectual property expenditures required to develop, market, and defend MAKO's
products. These and other risks are described in greater detail under Item 1A, "Risk Factors," in
MAKO's periodic filings with the Securities and Exchange Commission, including MAKO's annual
report on Form 10-K for the year ended December 31, 2010 filed on March 10, 2011. Given these
uncertainties, undue reliance should not be placed on these forward-looking statements. MAKO does
not undertake any obligation to release any revisions to these forward-looking statements publicly to
reflect events or circumstances after the date of this press release or to reflect the occurrence of
unanticipated events.
MAKO does and seeks to do engage healthcare professionals and entities in the development and
improvement of our products. Our policy statement and roster of healthcare professional partners are
available at http://www.makosurgical.com/site/index.php/company/business-conduct-2.
"MAKOplasty(R)," "RESTORIS(R)," and "RIO(R)," as well as the "MAKO" logo, whether standing alone
or in connection with the words "MAKO Surgical Corp." are trademarks of MAKO Surgical Corp.
1 Clinical Orthopaedics and Related Research. 2011:469(2):319-329.
2 Survey conducted by phone within the United States by Harris Interactive from June 16-June 20, 2011
among 1,631 adults ages 40 and older. Results were weighted to reflect the U.S. adult population.
3 AAOS Website http://orthoinfo.aaos.org/topic.cfm?topic=a00377
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: MAKO Surgical Corp
Next
A total hip replacement replaces your arthritic hip joint and eliminates the damaged bearing surfaces
that are causing you pain. The design of the implant offers you renewed stability and minimizes the
wear process.
http://www.bonesmart.org/hip_replacement.php?gclid=CMuKm6uP4JgCFSUgDQodmTzaeA
MAKO does hip replacements via a robotic system.
MAKO Surgical Corp. Introduces MAKOplasty(R) Total Hip Arthroplasty
8:00 AM ET 9/19/11 | GlobeNewswire
Robotic Arm-Assisted Technology Provides Surgeons With
Consistently Reproducible Precision in Hip Replacement Surgery
MAKOplasty Total Hip Arthroplasty is Designed to Help Surgeons Restore
Patient Mobility and Lifestyle
FT. LAUDERDALE, Fla., Sept. 19, 2011 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:
MAKO) today announced the commercial availability of the RIO(R) Robotic Arm Interactive
Orthopedic System for use in total hip replacement procedures, called MAKOplasty(R) Total Hip
Arthroplasty.
MAKO's total hip replacement application is designed to support the surgeon's ability to more
accurately align and position the implants relative to the needs of a patient. This may reduce potential
complications associated with conventional hip replacement surgery. MAKOplasty Total Hip
Arthroplasty provides a surgeon with a pre-operative 3-D reconstruction of the patient's hip and is
used to develop the patient-specific surgical plan. The robotic-arm then assists the surgeon during the
procedure to accurately prepare the joint and optimally place hip implants.
"MAKOplasty Total Hip Arthroplasty provides a significant advantage to me as a surgeon and to my
patients. It provides quantitative knowledge for what were difficult judgment decisions inherent in
manually performed operations," said Lawrence Dorr, M.D., founder and medical director of The Dorr
Arthritis Institute in Los Angeles. "When I finish a hip replacement I no longer am anxious to see the x-
ray because I know I've got the implants, leg length and offset correct. It makes recovery easier for
patients, including their comfort, activities and protection from dislocation. This robotic guided
operation is better for both me and my patients."
A recently published Massachusetts General Hospital study reported that, over a sustained period of
study of 1,823 hips, only 50 percent of acetabular cups (cup-shaped sockets of the hip joint) were
positioned in the acceptable range. Mal-positioning of acetabular cups in conventional hip replacement
surgery may lead to impingement that can cause dislocation, fracture, and increased implant wear.1
Nearly 300,000 primary hip replacement surgeries are performed annually in the United States using
conventional techniques.
"We're pleased to introduce MAKOplasty Total Hip Arthroplasty as an option for surgeons who
perform total hip replacement," said Maurice R. FerrÄ—, M.D., president and chief executive officer of
MAKO Surgical Corp. "We believe that surgeons and patients will benefit from a technology that can
help improve accuracy and precision in surgery and result in a potential reduction of the complications
reported from conventional approaches."
According to a June 2011 survey conducted by Harris Interactive, six in 10 adults ages 40+ are afraid
they will lose their ability to walk and/or move around without pain. Nearly nine out of 10 survey
respondents thought that hip replacement gives people back their independence and believe it can
restore a better quality of life.2
"With my hip pain, I really couldn't walk or sleep, and going up and down stairs was very painful,"
said Victoria Handy Smudzinski, 44, who has osteoarthritis of the hip and had a total hip replacement
with MAKOplasty. "I'm glad that I had the MAKOplasty procedure because already I am on my way
back to a normal life."
Approximately 10 million Americans suffer from osteoarthritis (OA) of the hip, or the wearing away of
the cartilage that cushions the bones of the hips, causing hip pain and stiffness, which can affect
mobility, including walking and bending. Hip OA is the most common cause of hip replacement
surgery.3
MAKOplasty Total Hip Arthroplasty is the newest application for MAKO's RIO robotic arm system
and builds upon five years of MAKO's existing MAKOplasty Partial Knee Resurfacing procedure for
patients with early to mid-stage osteoarthritis of the knee. MAKOplasty Total Hip Arthroplasty was
cleared for use in the U.S. by the FDA in February 2010.
About MAKO Surgical Corp.
MAKO Surgical Corp. is a medical device company that markets both its RIO(R) Robotic-Arm
Interactive Orthopedic system and its proprietary RESTORIS(R) implants for orthopedic knee and hip
procedures called MAKOplasty(R). The RIO is a surgeon-interactive tactile surgical platform that
incorporates a robotic arm and patient-specific visualization technology, which enables precise,
consistently reproducible bone resection for the accurate insertion and alignment of MAKO's
RESTORIS implants. The MAKOplasty solution is comprised of technologies enabled by an intellectual
property portfolio including more than 300 U.S. and foreign, owned and licensed, patents and patent
applications. Additional information can be found at www.makosurgical.com.
Forward-Looking Statements
This press release contains forward-looking statements regarding, among other things, statements
related to expectations, goals, plans, objectives and future events. MAKO intends such forward-
looking statements to be covered by the safe harbor provisions for forward-looking statements
contained in Section 21E of the Securities Exchange Act of 1934 and the Private Securities Reform Act
of 1995. In some cases, forward-looking statements can be identified by the following words: "may,"
"will," "could," "would," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict,"
"project," "potential," "continue," "ongoing" or the negative of these terms or other comparable
terminology, although not all forward-looking statements contain these words. These statements are
based on the current estimates and assumptions of our management as of the date of this press release
and are subject to risks, uncertainties, changes in circumstances, assumptions and other factors that
may cause actual results to differ materially from those indicated by forward-looking statements,
many of which are beyond MAKO's ability to control or predict. Such factors, among others, may have
a material adverse effect on MAKO's business, financial condition and results of operations and may
include the potentially significant impact of a continued economic downturn or delayed economic
recovery on the ability of MAKO's customers to secure adequate funding, including access to credit,
for the purchase of MAKO's products or cause MAKO's customers to delay a purchasing decision,
changes in competitive conditions and prices in MAKO's markets, unanticipated issues relating to
intended product launches, decreases in sales of MAKO's principal product lines, increases in
expenditures related to increased or changing governmental regulation or taxation of MAKO's
business, unanticipated issues in complying with regulatory requirements related to MAKO's current
products or securing regulatory clearance or approvals for new products or upgrades or changes to
MAKO's current products, the impact of the recently enacted United States healthcare reform
legislation on hospital spending, reimbursement, and the taxing of medical device companies, loss of
key management and other personnel or inability to attract such management and other personnel and
unanticipated intellectual property expenditures required to develop, market, and defend MAKO's
products. These and other risks are described in greater detail under Item 1A, "Risk Factors," in
MAKO's periodic filings with the Securities and Exchange Commission, including MAKO's annual
report on Form 10-K for the year ended December 31, 2010 filed on March 10, 2011. Given these
uncertainties, undue reliance should not be placed on these forward-looking statements. MAKO does
not undertake any obligation to release any revisions to these forward-looking statements publicly to
reflect events or circumstances after the date of this press release or to reflect the occurrence of
unanticipated events.
MAKO does and seeks to do engage healthcare professionals and entities in the development and
improvement of our products. Our policy statement and roster of healthcare professional partners are
available at http://www.makosurgical.com/site/index.php/company/business-conduct-2.
"MAKOplasty(R)," "RESTORIS(R)," and "RIO(R)," as well as the "MAKO" logo, whether standing alone
or in connection with the words "MAKO Surgical Corp." are trademarks of MAKO Surgical Corp.
1 Clinical Orthopaedics and Related Research. 2011:469(2):319-329.
2 Survey conducted by phone within the United States by Harris Interactive from June 16-June 20, 2011
among 1,631 adults ages 40 and older. Results were weighted to reflect the U.S. adult population.
3 AAOS Website http://orthoinfo.aaos.org/topic.cfm?topic=a00377
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: MAKO Surgical Corp
Next
 | |  | |  | |  | |  |